Cambridge Investment Research Advisors, Inc. Opko Health, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

  • $29.6 Billion
  • Q1 2025

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Opko Health, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 103,110 shares of OPK stock, worth $139,198. This represents 0.0% of its overall portfolio holdings.

Number of Shares
103,110
Previous 103,110 -0.0%
Holding current value
$139,198
Previous $152,000 12.5%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$1.4 - $1.64 $631 - $739
-451 Reduced 0.44%
103,110 $152,000
Q3 2024

Oct 28, 2024
SELL
$1.21 - $1.68 $1,257 - $1,745
-1,039 Reduced 0.99%
103,561 $154,000
Q2 2024

Jul 26, 2024
SELL
$1.21 - $1.42 $556 - $653
-460 Reduced 0.44%
104,600 $131,000
Q1 2024

Apr 24, 2024
SELL
$0.87 - $1.57 $9,725 - $17,551
-11,179 Reduced 9.62%
105,060 $126,000
Q4 2023

Feb 09, 2024
BUY
$1.23 - $1.63 $356 - $472
290 Added 0.25%
116,239 $176,000
Q3 2023

Oct 24, 2023
SELL
$1.5 - $2.17 $26,064 - $37,705
-17,376 Reduced 13.03%
115,949 $186,000
Q2 2023

Jul 13, 2023
BUY
$1.37 - $2.17 $1,850 - $2,931
1,351 Added 1.02%
133,325 $289,000
Q1 2023

May 11, 2023
SELL
$1.06 - $1.61 $3,248 - $4,934
-3,065 Reduced 2.27%
131,974 $193,000
Q4 2022

Feb 08, 2023
SELL
$1.05 - $2.01 $79,040 - $151,306
-75,277 Reduced 35.79%
135,039 $169,000
Q3 2022

Oct 17, 2022
SELL
$1.81 - $2.81 $92,536 - $143,661
-51,125 Reduced 19.56%
210,316 $397,000
Q2 2022

Jul 13, 2022
SELL
$2.33 - $3.61 $3,262 - $5,054
-1,400 Reduced 0.53%
261,441 $661,000
Q1 2022

May 12, 2022
SELL
$2.87 - $4.93 $14,774 - $25,379
-5,148 Reduced 1.92%
262,841 $904,000
Q4 2021

Feb 03, 2022
SELL
$3.52 - $5.15 $67,179 - $98,287
-19,085 Reduced 6.65%
267,989 $1.29 Million
Q3 2021

Nov 02, 2021
SELL
$3.44 - $4.24 $23,622 - $29,116
-6,867 Reduced 2.34%
287,074 $1.05 Million
Q2 2021

Aug 10, 2021
SELL
$3.33 - $4.55 $32,570 - $44,503
-9,781 Reduced 3.22%
293,941 $1.19 Million
Q1 2021

May 07, 2021
SELL
$4.19 - $5.99 $17,593 - $25,152
-4,199 Reduced 1.36%
303,722 $1.3 Million
Q4 2020

Feb 04, 2021
SELL
$3.27 - $4.87 $197,367 - $293,938
-60,357 Reduced 16.39%
307,921 $1.22 Million
Q3 2020

Oct 29, 2020
BUY
$2.99 - $5.96 $57,892 - $115,397
19,362 Added 5.55%
368,278 $1.36 Million
Q2 2020

Jul 27, 2020
SELL
$1.15 - $3.41 $31,854 - $94,457
-27,700 Reduced 7.35%
348,916 $1.19 Million
Q1 2020

May 08, 2020
SELL
$1.34 - $2.32 $11,357 - $19,664
-8,476 Reduced 2.2%
376,616 $504,000
Q4 2019

Feb 04, 2020
SELL
$1.42 - $2.17 $40,805 - $62,357
-28,736 Reduced 6.94%
385,092 $566,000
Q3 2019

Nov 06, 2019
SELL
$1.75 - $2.47 $9,999 - $14,113
-5,714 Reduced 1.36%
413,828 $864,000
Q2 2019

Aug 15, 2019
SELL
$1.79 - $2.61 $7,383 - $10,766
-4,125 Reduced 0.97%
419,542 $0
Q1 2019

May 08, 2019
BUY
$2.42 - $3.83 $197,007 - $311,792
81,408 Added 23.79%
423,667 $0
Q4 2018

Feb 05, 2019
SELL
$2.46 - $3.87 $109,083 - $171,607
-44,343 Reduced 11.47%
342,259 $1.03 Million
Q3 2018

Nov 02, 2018
SELL
$3.29 - $6.29 $106,734 - $204,060
-32,442 Reduced 7.74%
386,602 $0
Q2 2018

Aug 10, 2018
SELL
$2.99 - $4.99 $87,382 - $145,832
-29,225 Reduced 6.52%
419,044 $0
Q1 2018

May 09, 2018
SELL
$3.11 - $5.12 $127,382 - $209,710
-40,959 Reduced 8.37%
448,269 $0
Q4 2017

Feb 22, 2018
BUY
$4.61 - $7.04 $45,108 - $68,886
9,785 Added 2.04%
489,228 $0
Q3 2017

Nov 07, 2017
SELL
$5.88 - $7.11 $58,800 - $71,100
-10,000 Reduced 2.04%
479,443 $3.29 Million
Q2 2017

Aug 08, 2017
BUY
N/A
489,443
489,443 $3.22 Million

Others Institutions Holding OPK

# of Institutions
265
Shares Held
244M
Call Options Held
1.56M
Put Options Held
403K
View Full List

About OPKO HEALTH, INC.

OPK Quotes by TradingView
  • Ticker OPK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 771,960,000
  • Market Cap $1.04B
  • Description
  • OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...
More about OPK
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email